Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.72B |
| 2 |
Apple
AAPL
|
+$1.98B |
| 3 |
Microsoft
MSFT
|
+$1.42B |
| 4 |
Alibaba
BABA
|
+$1.03B |
| 5 |
Amazon
AMZN
|
+$924M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MNTA
Momenta Pharmaceuticals, Inc.
MNTA
|
+$261M |
| 2 |
AMTD
TD Ameritrade Holding Corp
AMTD
|
+$241M |
| 3 |
IMMU
Immunomedics Inc
IMMU
|
+$234M |
| 4 |
Keurig Dr Pepper
KDP
|
+$173M |
| 5 |
FedEx
FDX
|
+$150M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.19% |
| 2 | Healthcare | 7.18% |
| 3 | Consumer Discretionary | 7.09% |
| 4 | Financials | 5.3% |
| 5 | Industrials | 4.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4226
Agnico Eagle Mines
AEM
$113B
| $448K | ﹤0.01% |
+6,349
| New | +$474K |
|
|
MRNS
4227
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $448K | ﹤0.01% |
36,697
-310,295
| -89% | -$4.33M |
|
4228
AeroVironment
AVAV
$7.49B
| $447K | ﹤0.01% |
5,139
-755
| -13% | -$60.6K |
|
4229
PUT
GoodRx Holdings
GDRX
$1.19B
| $444K | ﹤0.01% |
+11,000
| New | +$505K |
|
4230
CALL
Illumina
ILMN
$34B
| $444K | ﹤0.01% |
1,234
-12,233
| -91% | -$3.9M |
|
4231
Northeast Bank
NBN
$1.09B
| $444K | ﹤0.01% |
+19,729
| New | +$417K |
|
4232
Ooma
OOMA
$566M
| $444K | ﹤0.01% |
30,848
-35,174
| -53% | -$520K |
|
4233
Culp Inc
CULP
$44.3M
| $442K | ﹤0.01% |
+27,873
| New | +$398K |
|
4234
CALL
Emerson Electric
EMR
$86.4B
| $442K | ﹤0.01% |
+5,500
| New | +$409K |
|
|
BBT
4235
Beacon Financial Corp
BBT
$2.63B
| $441K | ﹤0.01% |
+25,781
| New | +$385K |
|
|
BIOR
4236
DELISTED
Biora Therapeutics, Inc. Common Stock
BIOR
| $441K | ﹤0.01% |
332
-142
| -30% | -$208K |
|
|
BWG
4237
BrandywineGLOBAL Global Income Opportunities Fund
BWG
$129M
| $440K | ﹤0.01% |
+35,240
| New | +$416K |
|
|
4238
CALL
GoodRx Holdings
GDRX
$1.19B
| $440K | ﹤0.01% |
+10,900
| New | +$501K |
|
4239
Invesco Senior Income Trust
VVR
$453M
| $440K | ﹤0.01% |
+110,463
| New | +$416K |
|
4240
Piper Sandler
PIPR
$5.28B
| $439K | ﹤0.01% |
17,396
-126,304
| -88% | -$2.86M |
|
|
RDFN
4241
CALL
DELISTED
Redfin
RDFN
| $439K | ﹤0.01% |
+6,400
| New | +$342K |
|
|
RDFN
4242
PUT
DELISTED
Redfin
RDFN
| $439K | ﹤0.01% |
+6,400
| New | +$342K |
|
4243
Entravision Communication
EVC
$752M
| $438K | ﹤0.01% |
159,372
+103,085
| +183% | +$249K |
|
4244
Arcus Biosciences
RCUS
$4.02B
| $438K | ﹤0.01% |
16,872
-286,157
| -94% | -$6.93M |
|
|
ONEM
4245
PUT
DELISTED
1Life Healthcare
ONEM
| $437K | ﹤0.01% |
+10,000
| New | +$342K |
|
|
CMAXW
4246
CALL
DELISTED
CareMax, Inc. Warrant
CMAXW
| $437K | ﹤0.01% |
28,000
+5,000
| +22% | +$11K |
|
4247
Pro-Dex
PDEX
$208M
| $436K | ﹤0.01% |
14,084
+760
| +6% | +$26.9K |
|
|
URG
4248
CALL
Ur-Energy
URG
$589M
| $436K | ﹤0.01% |
+544,000
| New | +$297K |
|
4249
Liberty All-Star Equity Fund
USA
$1.84B
| $436K | ﹤0.01% |
+63,131
| New | +$405K |
|
|
HZN
4250
DELISTED
Horizon Global Corporation
HZN
| $435K | ﹤0.01% |
+50,630
| New | +$360K |
|
Similar funds
Israel Englander's Q4 2020 Portfolio in Review
As of Q4 2020, Israel Englander held 5,904 positions worth $138B, up 71% from $81.2B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Israel Englander deployed $41.4B of net new capital in Q4 2020, opening 1,518 new positions and adding to 1,899 existing holdings. Its largest new stake was Sotera Health: 2,269,458 shares worth $62.3M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 6.3% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Keurig Dr Pepper, an estimated $173M trimmed.
- Israel Englander's largest Q4 2020 buy was Sotera Health: 2,269,458 shares worth $62.3M.
- Israel Englander added most to State Street SPDR S&P 500 ETF Trust in Q4 2020, an estimated $2.72B increase.
- Israel Englander's biggest Q4 2020 reduction was Keurig Dr Pepper, cutting an estimated $173M.
- Israel Englander fully exited Momenta Pharmaceuticals, Inc. in Q4 2020, selling an estimated $261M.
- Israel Englander's ten largest holdings make up 20% of its $138B portfolio in Q4 2020.
- Israel Englander opened 1,518 new positions and closed 754 in Q4 2020.
- Israel Englander's portfolio value rose 71% quarter-over-quarter to $138B.
Based on Millennium Management's 13F filing for Q4 2020, filed 16 Feb 2021.